Research and resources

Biopharma Investor ESG Communications Guidance 2.0 - High Meadows Institute

Guidance that helps companies communicate their ESG narrative, including strategy, governance, risks, opportunities, and performance, in a well-structured and comparable manner.

Download this resource

(PDF download)

Enhancing the credibility of non-financial information: the investor perspective - WBCSD

This report explores what value this information has for investors, what could make it more reliable and what role assurance can play in increasing confidence in it.

View this resource

(opens webpage in new browser tab)

ESG and the Earnings Call - Harvard Law School Forum on Corporate Government

Issuers have begun experimenting with methods of building elements of ESG/SRI-type disclosures into earnings call content. A first step is to include greater ESG/SRI themes in call content.

View this resource

(opens webpage in new browser tab)

ESG Disclosure Handbook - WBCSD

This guide sets out a simple set of questions and steps that give companies a simple, clear and practical way of optimizing confidence in externally reported ESG information.

View this resource

(opens webpage in new browser tab)

ESG ratings - Sustainalytics

Database that enables companies to look up the how they (and a selection of their peers) are rated by Sustainalytics

View this resource

(opens webpage in new browser tab)

ESG ratings on companies - MSCI ESG Research

A searchable database of the ESG ratings assigned to companies by MSCI ESG Research

View this resource

(opens webpage in new browser tab)

ESG/SRI: Sustainability issues for IR (Training course) - Investor Relations Society

A half-day course that teaches participants how to respond to the growing interest of institutional investors in the sustainability performance and corporate governance practices of quoted companies.

View this resource

(opens webpage in new browser tab)

FAZ Novartis materiality assessment toolkit

A management tool for strategy setting

As part of its approach to holistic management, Novartis has designed a comprehensive “Materiality Assessment (MA) Toolkit” to identify topics and capture insights that are relevant for strategy-setting, steering and reporting.

Novartis now makes this toolkit available to all interested companies as an open-source project to support inclusive and holistic management worldwide.

View this resource

(opens webpage in new browser tab)

Global SRI & CG Diary - SRI-CONNECT

SRI-CONNECT maintains a calendar of major events in SRI & Corporate Governance. This will help companies to identify events at which they can learn about current developments in sustainable investment.  It will also help them to schedule their own investor outreach.

View this resource

(opens webpage in new browser tab)

Guide to Effective Proxies - ESG Chapter - DFIN

Companies are starting to incorporate highlights of their CSR/sustainability reports in their proxy statements. This brief guide provides a broad range of examples.

Download this resource

(PDF download)

IRRI 2019 - Institutional Investor

The IRRI Survey is the annual survey of the sustainable investment value chain and has documented sustainable investor communications practices over the past six years.

View this resource

(opens webpage in new browser tab)

Listing of signatories to the PRI - PRI

Companies can consult this listing for information on which of their investors have taken one of the first public steps in sustainable investment - by signing the Principles for Responsible Investment.

View this resource

(opens webpage in new browser tab)

Re-evaluating ESG performance post-COVID in the biopharma industry

In light of the COVID crisis, investors are re-examining how to measure companies’ sustainability performance. This article is based on research and conversations with investors, ESG and pharma industry experts.

Companies will need to continuously monitor changes in ESG rating frameworks and shifts in investors’ expectations. Although developments spurred by the pandemic are highly dynamic, we have ventured to take a brief snapshot of the trends that seem most significant for the pharmaceutical industry. This article outlines the main trends to watch post-COVID.

View this resource

(opens webpage in new browser tab)

Refreshing your materiality matrix - Finch & Beak

This article includes a discussion of coronavirus related factors that may influence a company's 'materiality matrix'

View this resource

(opens webpage in new browser tab)

Research Archive - MSCI ESG Research

Archive of MSCI ESG's reseach reports which provide useful context for any engagement with MSCI ESG analysts.

View this resource

(opens webpage in new browser tab)

Sustainable investor access - SRI-Connect & InterAxS Global

100% subsidised investor targeting and 'roadshow' organisation for companies that are exposed to the 'food & fibre transition'

Download this resource

(PDF download)

Telling your ESG Story - Intrado Digital Media

On-demand webinar that discusses how companies can create a consistent ESG message across different corporate websites, news releases, regulatory filings, video events and social media posts.

View this resource

(opens webpage in new browser tab)

The Reporting Exchange - WBCSD

The Reporting Exchange is a tool for people involved in preparing and delivering corporate sustainability, annual or integrated reports to help them navigate the often confusing world of corporate reporting.

View this resource

(opens webpage in new browser tab)

www.investESG.eu - InvestESG.eu

News & comment website featuring interviews, profiles and comment from regulators, standard-setters, asset owners, investment managers, NGOs, governments, scientists and other ESG experts.

View this resource

(opens webpage in new browser tab)